- HbA1C not associated with main outcome (p=0.28) or death (p=0.91) - Preadmission metformin use associated with lower mortality OR 0.59 (0.42, 0.84),- No association with other T2DM meds - OR mortality with insulin 1.71 (1.20, 2.43). The gene discussed is INS; the disease is type 2 diabetes mellitus.